RespirologyPub Date : 2025-01-01Epub Date: 2024-09-24DOI: 10.1111/resp.14832
Asha Bonney, Michelle Chua, Mark W McCusker, Diane Pascoe, Subodh B Joshi, Daniel Steinfort, Henry Marshall, Jeremy D Silver, Cheng Xie, Sally Yang, Jack Watson, Paul Fogarty, Emily Stone, Fraser Brims, Annette McWilliams, XinXin Hu, Christopher Rofe, Brad Milner, Stephen Lam, Kwun M Fong, Renee Manser
{"title":"Coronary artery calcification detected on low-dose computed tomography in high-risk participants of an Australian lung cancer screening program: A prospective observational study.","authors":"Asha Bonney, Michelle Chua, Mark W McCusker, Diane Pascoe, Subodh B Joshi, Daniel Steinfort, Henry Marshall, Jeremy D Silver, Cheng Xie, Sally Yang, Jack Watson, Paul Fogarty, Emily Stone, Fraser Brims, Annette McWilliams, XinXin Hu, Christopher Rofe, Brad Milner, Stephen Lam, Kwun M Fong, Renee Manser","doi":"10.1111/resp.14832","DOIUrl":"10.1111/resp.14832","url":null,"abstract":"<p><strong>Background and objectives: </strong>Coronary artery calcification (CAC) is a frequent additional finding on lung cancer screening (LCS) low-dose computed tomography (LDCT). Cardiovascular disease (CVD) is a major cause of death in LCS participants. We aimed to describe prevalence of incidental CAC detected on LDCT in LCS participants without prior history of coronary artery disease (CAD), evaluate their CVD risk and describe subsequent investigation and management.</p><p><strong>Methods: </strong>Prospective observational nested cohort study including all participants enrolled at a single Australian site of the International Lung Screen Trial. Baseline LDCTs were reviewed for CAC, and subsequent information collected regarding cardiovascular health. 5-year CVD risk was calculated using the AusCVD risk calculator.</p><p><strong>Results: </strong>55% (226/408) of participants had CAC on LDCT and no prior history of CAD, including 23% with moderate-severe CAC. Mean age of participants with CAC was 65 years, 68% were male. 53% were currently smoking. Majority were high risk (51%) or intermediate risk (32%) of a cardiovascular event in 5 years. 21% of participants were re-stratified to a higher CVD risk group when CAC detected on LCS was incorporated. Only 10% of participants with CAC received lifestyle advice (only 3% currently smoking received smoking cessation advice). 80% of participants at high-risk did not meet guideline recommendations, with 47% of this group remaining without cholesterol lowering therapy.</p><p><strong>Conclusion: </strong>LCS with LDCT offers the potential to identify and communicate CVD risk in this population. This may improve health outcomes for high-risk LCS participants and further personalize management once screening results are known.</p>","PeriodicalId":21129,"journal":{"name":"Respirology","volume":" ","pages":"62-69"},"PeriodicalIF":6.6,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11688628/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142352912","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
RespirologyPub Date : 2025-01-01Epub Date: 2024-12-10DOI: 10.1111/resp.14869
Raglan Maddox, Lisa J Whop
{"title":"Indigenous peoples, tobacco use and the role of the commercial tobacco industry.","authors":"Raglan Maddox, Lisa J Whop","doi":"10.1111/resp.14869","DOIUrl":"10.1111/resp.14869","url":null,"abstract":"","PeriodicalId":21129,"journal":{"name":"Respirology","volume":" ","pages":"21-24"},"PeriodicalIF":6.6,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11688626/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142807800","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
RespirologyPub Date : 2025-01-01Epub Date: 2024-08-29DOI: 10.1111/resp.14821
Rodrigo Torres-Castro, Williams Hinojosa, Amaya Martínez-Meñaca, Ernest Sala Llinas, Josefa Jiménez Arjona, Joaquín Rueda Soriano, Agueda Aurtenetxe, Joan Albert Barberà, Pilar Escribano-Subías, Isabel Blanco
{"title":"Epidemiology of supplemental oxygen in patients with pulmonary hypertension.","authors":"Rodrigo Torres-Castro, Williams Hinojosa, Amaya Martínez-Meñaca, Ernest Sala Llinas, Josefa Jiménez Arjona, Joaquín Rueda Soriano, Agueda Aurtenetxe, Joan Albert Barberà, Pilar Escribano-Subías, Isabel Blanco","doi":"10.1111/resp.14821","DOIUrl":"10.1111/resp.14821","url":null,"abstract":"<p><strong>Background and objective: </strong>Patients with pulmonary hypertension (PH) may present with hypoxaemia at rest or during daily activities. There is no epidemiological data on the prescription of long-term oxygen therapy (LTOT) in patients with PH. The study sought to analyse the prevalence and incidence of LTOT prescription among patients with pulmonary arterial hypertension (PAH) or chronic thromboembolic pulmonary hypertension (CTEPH) in Spain and to determine predictors for this prescription.</p><p><strong>Methods: </strong>A retrospective analysis was performed from the Spanish Registry of Pulmonary Arterial Hypertension (REHAP). Collected data included demographics and anthropometric measurements, functional class (FC), arterial blood gases, pulmonary function tests, haemodynamic measurements, six-minute walking distance (6MWD) and LTOT prescription. In addition, we assessed the prevalence and incidence of LTOT prescription by PH group and subtype and potential predictors for LTOT initiation in the first 5 years after diagnosis.</p><p><strong>Results: </strong>We analysed 4533 patients (69.9% PAH and 30.1% CTEPH), mostly female (64.5%), with a mean age of 53.0 ± 18.3 years. The prevalence of LTOT was 19.3% for all patients. The incidence of LTOT prescriptions decreased from 5.6% to 1.6% between 2010 and 2019, respectively. Predictors for LTOT prescription, excluding those that represent the indication for oxygen therapy were: FC (HR: 1.813), 6MWD (HR: 1.002), mean pulmonary arterial pressure (mPAP) (HR: 1.014), cardiac index (CI) (HR: 1.253), pulmonary vascular resistance (PVR) (HR: 1.023) and diffusing capacity of carbon monoxide (DL<sub>CO</sub>) (HR: 1.294).</p><p><strong>Conclusion: </strong>The prevalence of LTOT in PAH and CTEPH patients is close to 20%. FC, 6MWD, mPAP, CI, PVR and DL<sub>CO</sub> were predictors for LTOT prescription.</p>","PeriodicalId":21129,"journal":{"name":"Respirology","volume":" ","pages":"70-79"},"PeriodicalIF":6.6,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142111460","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
RespirologyPub Date : 2025-01-01Epub Date: 2024-12-04DOI: 10.1111/resp.14860
Tracy L Leong
{"title":"Bringing down two Goliaths with one stone: Reducing lung cancer and cardiovascular mortality with low-dose CT screening.","authors":"Tracy L Leong","doi":"10.1111/resp.14860","DOIUrl":"10.1111/resp.14860","url":null,"abstract":"","PeriodicalId":21129,"journal":{"name":"Respirology","volume":" ","pages":"18-20"},"PeriodicalIF":6.6,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142780885","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
RespirologyPub Date : 2025-01-01Epub Date: 2024-11-29DOI: 10.1111/resp.14861
David C L Lam
{"title":"World Pneumonia Day 2024-Fighting pneumonia, antibiotic resistance and pollution.","authors":"David C L Lam","doi":"10.1111/resp.14861","DOIUrl":"10.1111/resp.14861","url":null,"abstract":"","PeriodicalId":21129,"journal":{"name":"Respirology","volume":" ","pages":"82-83"},"PeriodicalIF":6.6,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142751250","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
RespirologyPub Date : 2025-01-01Epub Date: 2024-10-28DOI: 10.1111/resp.14850
Joyce W Y Chan, Calvin S H Ng
{"title":"Transbronchial ablation for lung cancers: Ready for prime time?","authors":"Joyce W Y Chan, Calvin S H Ng","doi":"10.1111/resp.14850","DOIUrl":"10.1111/resp.14850","url":null,"abstract":"","PeriodicalId":21129,"journal":{"name":"Respirology","volume":" ","pages":"16-17"},"PeriodicalIF":6.6,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142522855","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
RespirologyPub Date : 2025-01-01Epub Date: 2024-11-14DOI: 10.1111/resp.14855
Karen Royals, Sheree Smith
{"title":"Leading women in respiratory clinical sciences: Letter from Australia.","authors":"Karen Royals, Sheree Smith","doi":"10.1111/resp.14855","DOIUrl":"10.1111/resp.14855","url":null,"abstract":"<p><p>Special Series: Leading Women in Respiratory Clinical Sciences Series Editors: Anne-Marie Russel and Kathleen O Lindell See related Editorial.</p>","PeriodicalId":21129,"journal":{"name":"Respirology","volume":" ","pages":"86-87"},"PeriodicalIF":6.6,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142627014","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
RespirologyPub Date : 2025-01-01Epub Date: 2024-11-25DOI: 10.1111/resp.14862
{"title":"Correction to \"APSR Annual Conference - 28th Congress of the Asian Pacific Society of Respirology, 7-10 November 2024, Hong Kong. Respirology 29 (Suppl. 3)\".","authors":"","doi":"10.1111/resp.14862","DOIUrl":"10.1111/resp.14862","url":null,"abstract":"","PeriodicalId":21129,"journal":{"name":"Respirology","volume":" ","pages":"88"},"PeriodicalIF":6.6,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142717005","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
RespirologyPub Date : 2025-01-01Epub Date: 2024-11-24DOI: 10.1111/resp.14858
Bridget F Collins, Ganesh Raghu
{"title":"Hypersensitivity pneumonitis: A high index of clinical suspicion is key for early diagnosis and successful treatment.","authors":"Bridget F Collins, Ganesh Raghu","doi":"10.1111/resp.14858","DOIUrl":"10.1111/resp.14858","url":null,"abstract":"","PeriodicalId":21129,"journal":{"name":"Respirology","volume":" ","pages":"10-12"},"PeriodicalIF":6.6,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142710942","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}